Identification and purification of Ca2+/calmodulin-dependent protein kinase V from human gastric carcinoma  by Ohta, Hidemasa et al.
ELSEVIER Biochimica et Biophysica Acta 1317 (1996) 175-182 
BB Biochi~ic~a 
et Biophysica A~ta 
Identification and purification of Ca2+/calmodulin-dependent protein 
kinase V from human gastric carcinoma 
Hidemasa Ohta a, Ichiro Niki a, Tadashi Ito b Makoto Kato b, Yuji Nimura b, 
Nobuteru Usuda c, Hiroyoshi Hidaka a, * 
a Department of Pharmacology, Nagoya University School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466, Japan 
b First Department of Surgery, Nagoya University School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466, Japan 
c Department of Anatomy and Cell Biology, Shinshu University School of Medicine, Matsumoto, Japan 
Received 7August 1996; accepted 3September 1996 
Abstract 
We previously purified a novel Ca 2 ÷/calmodulin-dependent pro ein kinase (CaM kinase) V, which has proven to be a member of the 
CaM kinase I family. Immunohistochemical st ining of surgically-resected specimens from human subjects using specific antibody which 
reacts with CaM kinases I and V demonstrated heterogeneous di tribution of CaM kinase I /V  in normal gastric mucosa. The kinase was 
located mainly at the bottom of foveoral epithelium and in the gastric gland (< 25% immunopositive). In contrast, this kinase was 
abundant in various types of gastric carcinomas (> 75%), but not in gastric adenomas. Preferential nd consistent presence of this kinase 
was confirmed by immunoblot analysis of gastric carcinoma nd human gastric ancer cell lines, Kato-III and MKN-45. CaM kinase I /V  
was co-purified with CaM kinase II from resected gastric arcinoma using anion-exchange chromatography followed by calmodulin-affin- 
ity chromatography. The two kinases were finally separated by HPLC-based gel filtration. Purified CaM kinase I /V  from gastric 
carcinoma did not possess detectable autophosphorylating activity, in contrast to CaM kinase II. The findings suggest CaM kinase I /V  
may possess abnormal biochemical properties in human gastric carcinoma, and the kinase could participate in cell growth of the 
carcinoma. 
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1. Introduction 
Ca > is an important second messenger which partici- 
pates in various cellular functions including hormone re- 
lease, long-term potentiation, muscle contraction, gene ex- 
pression and cell growth. Calcium-binding proteins, pre- 
sent in a wide variety of tissues with heterogeneous tissue 
distribution, are responsible for the intracellular transduc- 
tion of Ca 2 ÷ signaling. 
The EF hand proteins form a family of calcium-binding 
proteins with 2 -6  EF hand structures which bind Ca 2÷. 
Abbreviations: CaM kinase, CaZ+/calmodulin-dependent pro ein ki- 
nase; DTT, dithiothreitol; PBS, phosphate-buffered saline; PMSF, phenyl- 
methylsulfonyl fluoride; SDS-PAGE, sodium dodecyl sulfate-polyacryl- 
amide gel electrophoresis; KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N- 
methyl-L-tyrosyl]-4-phenylpiperazine; W-7, N-(6-aminohexyl)-5-chloro- 
1-naphthalenesulfonamide 
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Interestingly, some members of the EF hand family, such 
as calcyclin, nephrocalcin and oncomodulin exhibit a dis- 
tinct localization in several types of tumor cells [1-3]. 
Calmodulin, one of the best characterized calcium-binding 
proteins, has also been reported to be more distributed in 
tumor cells in a specific manner [4], which has been 
verified in different types of carcinoma cells [5,6]. This 
calcium-binding protein activates everal enzymes includ- 
ing Ca2+/calmodulin dependent protein kinases (CaM ki- 
nases) [7]. At least six different ypes of CaM kinases have 
been found [8,9]. We recently purified CaM kinase V from 
rat brain [10], which has proved to be a member of the 
CaM kinase I family [11]. The CaM kinase I family exist 
in various tissues with a distribution distinct from that of 
CaM kinase II [12]. A large number of endogenous pro- 
teins in the brain are phosphorylated by CaM kinase V 
[13], which implies that the kinase may play a crucial role 
in various cellular functions. Recent studies have revealed 
that CaM kinase I and V share common properties includ- 
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ing their substrate specificities and partial amino acid 
sequences, although KN-62, the selective inhibitor of CaM 
kinases, inhibits CaM kinase V more potently than CaM 
kinase I [14]. It was therefore suggested that these two 
kinases, as well as CaM kinases Ia and Ib, are the mem- 
bers of the CaM kinase I family [11,15]. In the present 
paper, we report that CaM kinase I /V  is preferentially 
distributed in human gastric carcinoma nd also detail its 
purification and preliminary characterization f its proper- 
ties from surgically-resected materials. 
2. Mater ia l s  and  methods  
of undifferentiated a enocarcinoma (8 of poorly differenti- 
ated adenocarcinoma and 1 of mucinous adenocarcinoma) 
with the patients' permission. Surgically resected gastric 
adenoma was obtained from 4 patients. Distribution of the 
kinase was also examined in pathologically normal regions 
of these specimens. Profiles of these patients has been 
shown in Table 1. One of the specimen of poorly differen- 
tiated adenocarcinoma was used for protein purification 
and further characterization. The resected material was 
immediately frozen in liquid N 2, and stored at -80°C for 
further experiments. Histological typings were in accor- 
dance with the Japanese Classification of Gastric Carci- 
noma [ 16]. 
2.1. Materials 2.3. Cell culture 
DEAE Cellulose (DE 52) was purchased from What- 
man International (Maidstone, UK) and CNBr-activated 
Sepharose 4B from Pharmacia LKB (Uppsala, Sweden). 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) molecular mass standards were from Bio-Rad 
Laboratories (Hercules, CA). Tris, EGTA, Tween 20, 
dithiothreitol (DTT) and phenylmethylsulfonyl fluoride 
(PMSF) were from Wako Pure Chemical (Tokyo, Japan), 
and protein assay reagents from Pierce Chemical Co. 
(Rockford, IL). RPMI 1640 medium and kanamycin sul- 
phate were from Nissui Seiyaku (Tokyo, Japan) and from 
Meiji Seika (Tokyo, Japan), respectively. Biotinylated 
anti-guinea pig IgG and avidin-biotinylated peroxidase 
complex were from Vector Laboratories (Burlingame, CA). 
All other chemicals were of the highest grade available. 
2.2. Patients 
Human gastric carcinoma was obtained surgically from 
18 patients including 9 cases of differentiated adeno- 
carcinoma (1 of well-differentiated a enocarcinoma, 8 of 
moderately differentiated adenocarcinoma) and also 9 cases 
The human gastric cancer cell line Kato-III was derived 
from the pleural effusion of signet ring cell carcinoma, and 
another cell line MKN-45, was from the liver metastasis of 
a poorly differentiated adenocarcinoma [17]. These cell 
lines were gifts from the Japanese Cancer Research Re- 
sources Bank (Tokyo, Japan). They were cultured in RPMI 
1640 medium supplemented with 10% fetal bovine serum. 
Kanamycin sulphate at 200 mg/ l  was also added to the 
medium. Cells were incubated at 37°C in a humidified 
atmosphere of 5% CO2/95% air and passaged every 2 
days. 
2.4. Polyclonal antibody against CaM kinase V 
Anti-CaM kinase V antibody was raised by injecting a 
peptide synthesized on the basis of the partial amino acid 
sequence of CaM kinase V into guinea pigs [13]. In 
preliminary experiments, we established that the antibody 
does not react with purified CaM kinase II, but cross-reacts 
with CaM kinase I on immunoblotting [11], since these 
two CaM kinases share much of there amino acid se- 
quences [18]. Therefore, we have applied the term CaM 
kinase I /V  for descriptive purposes in this manuscript. 
Table 1 
Characteristics of the patients 
Carcinoma (n = 18) 
Age (mean and range, yr) 
Sex (male/female) 
Histological typing * 
Well-differentiated adenocarcinoma (n = 1 ) 
Moderately differentiated a enocarcinoma (n = 8) 
Poorly differentiated a enocarcinoma (n = 8) 
Mucinous adenocarcinoma (n = 1) 
Adenoma (n = 4) 
Age (mean and range, yr) (64,43-76) 
Sex (male/female) (2/2) 
(53.2, 31-61) 
(15/3) 
n, number of the patients. 
* Histological typings were in accordance with the Japanese Classifica- 
tion of Gastric Carcinoma [ 16]. 
2.5. Immunohistochemistry 
Resected specimens fixed in 4% paraformaldehyde w re 
dehydrated in an ethanol series and xylene, and embedded 
in paraffin. After rehydration, they were incubated in 
phosphate-buffered saline (PBS) containing 2% normal 
horse serum for 30 min, and anti-CaM kinase I /V  anti- 
body diluted 1:200 in PBS for 12 h. After washing in PBS, 
they were exposed to biotinylated anti-guinea pig IgG for 
1 h and the avidin biotinylated peroxidase complex for 1 h 
[19]. Some sections were treated in a microwave oven for 
antigen retrieval [20]. Visualization of bound antibodies 
was carried out by incubation with 0.05% 3,3'-diamino- 
benzidine tetrahydrochloride and 0.01% hydrogen peroxide 
in 50 mM Tris-HC1 buffer, pH 7.5. 
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2.6. Gel electrophoresis and immunoblotting 
SDS-PAGE was performed according to the method of 
Laemmli [21] on a 10% (wt/vol) acrylamide gel. Proteins 
were transferred electrophoretically onto Immobilon P 
(Millipore, Bedfold, MA) as described earlier [22]. Anti- 
gen-antibody complexes were visualized by reaction with 
3,3'-diaminobenzidine t trahydrochloride and hydrogen 
peroxide. 
2. 7. CaM kinase assay 
The standard assay mixture contained, in a final volume 
of 100 /zl, 35 mM Hepes, pH 8.0, 10 mM MgC12, 1 mM 
CaC12, 0.1 mM DIT,  0.005% Tween 20, 1.5 /~M calmod- 
ulin, 10 /~M [T-32p]ATP (200cpm/pmol) and 50 /xM 
syntide-2, y-Peptide was also used as a substrate when 
appropriate. Reaction was carded out at 37°C for 10 min. 
Incorporation of 32p into these substrates was measured 
essentially according to the method of Roskoski [23]. At 
the end of the 10 min incubation, 50 /xl aliquots of 
reaction mixture were spotted onto phosphocellulose paper 
(P-81, 2 cm in diameter, Whatman) and immediately 
soaked in 75 mM phosphoric acid. The phosphocellulose 
paper was then washed three times for 10 min each in 75 
mM phosphoric acid and dried. The radioactivity on the 
filter was determined by Cerenkov counting. 
homogenized in 10 volumes of homogenizing buffer con- 
raining 50 mM Tris-HC1, pH 7.6, 1 mM EGTA, 1 mM 
DTT, 1 mM PMSF and 10 /zg/ml leupeptin. For enzyme 
purification, the homogenates were treated as follows. 
After centrifugation at 100000 X g for 1 h, the supernatant 
was applied to a DE-52 column (6 X 3 cm) equilibrated 
with buffer A (40 mM Tris-HCl, pH 7.6, 1 mM Dq-T and 
0.05% Tween 20). After washing the column with buffer 
A, proteins were eluted with 150 ml of buffer containing 
500 mM NaC1. Ca 2 ÷ concentration of the pooled fraction 
was adjusted with CaC12 to a final concentration of 2 mM 
and it was then applied to a calmodulin-Sepharose 4B 
column (3 × 10 cm). The column was washed with buffer 
A containing 0.5 mM CaC12 and 1 M NaCI. CaM kinase 
I /V  was eluted with 50 ml of buffer A supplemented with 
4 mM EGTA. The active fractions were applied to gel- 
filtration chromatography, using PC 3.2/30 (1.5 × 30 cm; 
Pharmacia LKB) equilibrated with buffer B (40 mM Tris- 
HC1, pH 7.6, 1 mM DTI" and 0.2 M NaC1) and a 
SMART TM system (Pharmacia LKB). Proteins were sepa- 
rated at a flow rate of 40/z l /min,  and 50/xl aliquots were 
serially collected for kinase assay and immunoblotting. 
CaM-dependent kinase assay for these fractions were car- 
ried out after the Ca 2+ concentration was readjusted to 
0.55mM by the addition of CaC12. 
2.9. CaM kinase autophosphoryIation 
2.8. Purification of CaM kinase I /V  
All procedures for enzyme purification were carried out 
at 0-4°C. The resected human gastric carcinoma was 
Autophosphorylation f CaM kinases was carried out in 
a final volume 100 /zl under the standard assay conditions 
(see above), except that syntide-2 was omitted and that 
[ y_ 32 P]ATP with a higher specific activity (750 cpm/pmol) 
Fig. 1. Immunohistochemical staining of normal human gastric mucosa using anti-CaM kinase I/V antibody. Normal portion of gastric mucosa in the 
resected specimens were stained by anti-CaM kinase I/V kinase antibody. CaM kinase I/V-like immunoreactivity wasobserved in less than 25% of the 
gastric gland cells both in the pyloric region (a) and in the fundic region (b). (c) is the magnified image of the fundic gland. (a) and (b), bar = 50 p.m, (c), 
bar = 30 /xm. 
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was added to the mixture. After incubation at 37°C for 3 
min, 10 /~1 of SDS-PAGE sample buffer (200 mM Tris- 
HCI, pH 6.8, 30% glycerol, 2% SDS, 5 mM EGTA, 6% 
2-mercaptoethanol and 0.001% bromophenol blue) was 
added to the assay mixture. 30/x l  samples were subjected 
to SDS-PAGE, and 32p incorporation was visualized by 
autoradiography using the Fujix BAS 2000 system (Fuji 
Film, Tokyo, Japan). 
2.10. Other procedures 
Anti-CaM kinase II antibody was prepared in rabbits 
and affinity purified as described [24]. Protein concentra- 
tion was estimated by the method of Smith et al. [25] using 
bovine serum albumin as a standard. 
3. Results 
3.1. Indirect immunohistochemistry of normal human gas- 
tric mucosa and gastric carcinoma cells using anti-CaM 
kinase I /V  antibody 
Immunohistological studies demonstrated that CaM ki- 
nase I /V  was expressed in the gastric gland (Fig. 1). In 
the pyloric region, the gastric gland exhibited the CaM 
kinase I /V- l ike immunoreactivity in a scattered pattern 
( < 25% positive) in nine out of thirteen cases, and in the 
upper portion of foveoral epithelium, the immunoreactivity 
was also found in five cases but only in a small population 
( < 5%, Fig. la). Such was slightly different in the fundic 
region, where CaM kinase I /V  was also distributed in the 
Fig. 2. Comparison of CaM kinase I/V like immunoreactivity between gastric arcinomas nd adenoma. Surgically resected specimens ofhuman gastric 
carcinoma were used for indirect immunohistochemical st ining with anti-CaM kinase I/V antibody. Four different histological types are shown. (a) 
well-differentiated a enocarcinoma; (b) moderately differentiated adenocarcinoma; (c) poorly differentiated adenocarcinoma; (d) mucinous adeno- 
carcinoma; (e) shows negative staining of gastric adenoma with the CaM kinase I/V antibody. Bar = 50 /xm. 
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Fig. 3. Intracellular localization of CaM kinase I /V  in gastric carcinoma 
cells. Slices of surgically-resected human gastric carcinoma were fixed 
and stained using anti-CaM kinase I /V  antibody in the absence (a) or 
presence (b) of a peptide synthesized on the basis of the partial sequence 
of CaM kinase I /V.  CaM kinase I/V-like immunoreactivity was visual- 
ized by peroxidase reaction. Bar = 10 /xm. 
gastric gland (< 25% positive) in all five cases, but the 
immunoreactivity was not detected in the foveoral epithe- 
lium at all (Fig. l b). 
In contrast to the distribution i  normal gastric mucosa, 
CaM kinase I /V  was strongly and consistently (> 75% 
positive) expressed in the tumor cells for all the eighteen 
cases examined in the present study. Fig. 2 (a-d) shows 
preferential existence of CaM kinase I /V  in gastric adeno- 
carcinoma with four different histological types. CaM 
kinase I/V-like immunoreactivity was also examined in 
the gastric adenoma cells, where three cases out of four 
were negatively stained (Fig. 2e), with one exception (not 
shown). 
3.2. Immunohistochemical st ining and immunoblot analy- 
sis of the poorly differentiated adenocarcinoma ofgastric 
carcinoma 
The distribution of CaM kinase I /V  in surgically-ob- 
tained human gastric carcinoma is illustrated in Fig. 3a. 
CaM kinase I/V-like immunoreactivity was mainly lo- 
cated in the cytoplasm of the carcinoma tissue and normal 
gastric mucosa (Figs. 3 and lc, respectively). The 
immunoreactivity was abolished when the antibody was 
preabsorbed with a synthesized peptide based on the par- 
tial amino acid sequence of the antigen (Fig. 3b). 
When equal amounts of proteins (0.5tzg) extracted from 
gastric carcinoma nd normal gastric mucosa were exam- 
ined by Western blotting using anti-CaM kinase I /V  
antibody, a single band at 41kDa was found in human 
gastric arcinoma (Fig. 4, lane 2), but not in normal gastric 
Origin 
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Fig. 4. Immunoblot analysis of surgically-dissected gastric adeno- 
carcinoma nd cell lines derived from human gastric carcinoma. Ho- 
mogenates of human gastric carcinoma (lane 2) and normal gastric 
mucosa (lane 3) were analysed by Western blotting with anti-CaM kinase 
I /V  antibody. These samples (0.5 /xg protein per lane) were semi-puri- 
fied before loading onto the SDS-PAGE gel as described in Section 2. As 
a positive control, purified CaM kinase V (0.05 /zg) was loaded in 
parallel (lane 1). 50 /.rg protein samples of homogenates of MKN-45 
(lane 4) and Kato-III (lane 5) were also prepared and loaded without any 
purification step. 
mucosa (lane 3). The immunopositive band at 41kDa was 
consistently observed in the cultured gastric arcinoma cell 
lines, MKN-45 (lane 4) and Kato-III (lane 5), particularly 
in the latter. 
3.3. Purification of CaM kinase I /V  .from the ho- 
mogenates of  human gastric carcinoma 
The DEAE-Cellulose and calmodulin-Sepharose st ps 
resulted in 16.8- and 2690-fold purification of CaM kinase 
I /V, respectively. The elution profile from the HPLC 
column for UV protein detection (absorbance at280 nm) is 
illustrated in Fig. 5 (dotted line), with two peaks at approx. 
20000" - 0.04 
~ 0.09 
• ~ 1o~ 0.03 ~ 
/, ° "y /  o 
0.00 
10  20  30  
Fract ion Number  
Fig. 5. Purification of CaM kinase I /V  from human gastric carcinoma 
using HPLC, After ion-exchange chromatography and calmodulin-affinity 
chromatography, the peak fractions with CaM kinase activity was concen- 
trated and loaded onto a PC 3.2/30 gel filtration column using a SMART 
system. Elution was carried out at 40 pA/min and 50 /xl aliquots were 
collected in series. This figure illustrates the kinase activity (solid line) 
and absorbance at280 nm (dotted line) of the fractions. 
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600 kDa and 230 kDa. When the kinase activity was 
assayed using syntide-2 as a substrate in the presence of 1 
mM CaCI 2 and 1.5 /zM calmodulin, three peaks appeared 
at approx. 600, 230 and 40 kDa (Fig. 5, solid line) after 
this HPLC step. We could not detect any visible band 
around the 40 kDa protein even by silver staining. The 
kinase activity shown in Fig. 5 was abolished in the 
presence of 10 mM EGTA and using y-peptide, a selective 
peptide substrate of CaM kinase IV as a substrate, was not 
phosphorylated by these kinase fractions (data not shown). 
3.4. Immunoblotting of purified CaM kinases I /V  and H 
Western blotting using antibodies against CaM kinases 
I /V  and II (Fig. 6A and B, respectively) revealed the 
presence of these kinases in the purified fractions from 
human gastric cancer. In Fig. 6B, it was suggested that the 
dominant band was with an apparent molecular weight at 
50 kDa, which is correlated to the ce subunit of CaM 
kinase II [26]. Note that a weak band was also observed at 
60 kDa (/3 subunit) only in the fraction no. 9 in Fig. 5. 
The first peak in the kinase assay seems to be a oligomer 
A 
Front 
B 
Origin 
Origin 
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43KDa~ 
31KDa~ 
97KDa~ 
66KDa 
43KDa~ 
31KDa~ 
Front 
Fig. 6. Western blotting of purified CaM kinases I /V  and II. After 
separation on an HPLC column, immunoreactivity of the fractions was 
analysed by Western blotting using antibodies against CaM kinase I /V  
(A) and CaM kinase II (B). Visualization of the immunopositive bands 
were achieved by peroxidase reaction. 
1.2 .  3 .4 .  
66K Da.--~- 
43KDa--)- 
31K D a---~ 
Fig. 7. Autophosphorylation of partial purified CaM kinases I /V  and II. 
The HPLC fractions with peak CaM kinase activities were incubated with 
[T-32p] ATP and calmodulin in the presence of Ca ~+ for 3 rain. The 
reaction was terminated by addition of SDS-sample buffer. Samples were 
separated by SDS-PAGE and analysed by autoradiography. Lanes 1 and 2 
are peak fractions for CaM kinases II and I /V  from gastric carcinoma, 
respectively. Lanes 3 and 4 are partially purified CaM kinases II and V 
from rat brain, respectively. In lanes 1-3, an autophosphorylated band at 
50 kDa was consistently found. In lane 4, CaM kinase I /V  at 41 kDa was 
phosphorylated. Note that a higher band at 64 kDa is the activator kinase 
of CaM kinase I /V.  
from CaM kinase II. The second peak in Fig. 5, however, 
was not correlated with the intensity of immunopositive 
band on the Western blotting by the two antibodies (frac- 
tion no. 15 in Fig. 5). CaM kinase I /V  activity was found 
as the third peak in the kinase assay (fractions nos. 17-19), 
since the peak was well correlated with the immuno- 
reactivity on the immunoblotting by antibody against CaM 
kinase I /V  (Fig. 6A). In these fractions, however, very 
faint CaM kinase II-like immunoreactivity was also pre- 
sent (Fig. 6B). 
3.5. Autophosphorylation f purified CaM kinases 
Fig. 7 demonstrates autoradiography results for purified 
CaM kinases I /V  and II. Incubation of the CaM kinase II 
active fraction (fraction no. 9 in Fig. 5) with [ y-32 P]-ATP 
resulted in a single radioactive band at 50 kDa (Fig. 7, lane 
1) which was identical to the position of the autophospho- 
rylated a subunit of CaM kinase II from rat brain (Fig. 7, 
lane 3). The active fraction for CaM kinase I /V  from 
gastric carcinoma (fraction o. 19 in Fig. 5), however, did 
not undergo detectable autophosphorylation (Fig. 7, lane 
2). The control of CaM kinase I /V  (Fig. 7, lane 4), 
demonstrated phosphorylation f a higher band at 64 kDa 
as well as 41 kDa. We assume that the 64 kDa band in 
lane 4 is the associated kinase activator of CaM kinase 
I /V  [27]. In lane 2, co-existing CaM kinase II at 50 kDa, 
was also autophosphorylated. Re-mixing of these peak 
fractions did not cause any substantial changes (data not 
shown). 
4. Discussion 
In the present experiments, we found that CaM kinase 
I /V  to be expressed at much higher levels in gastric 
carcinoma than in normal gastric mucosa using an im- 
munohistochemical approach. We also demonstrated its 
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presence in cultured human gastric carcinoma cell lines. 
We have recently found that CaM kinase I /V  is abundant 
in various types of endocrine neoplasms, including human 
medullary carcinoma of the thyroid gland (Kato, M., Ohta, 
H. and Hidaka, H. unpublished ata). These findings sug- 
gest that protein phosphorylation via CaM kinase I /V  may 
play a role of particular importance to the cellular func- 
tions of these tumor cells, and this kinase would be a 
histological marker for gastric carcinoma. Indeed, other 
Ca2+-dependent protein kinases are also abundant in sev- 
eral types of human neoplasms. For example, protein 
kinase C is overexpressed in thyroid papillary carcinoma 
cells [28] and CaM kinase II is abundant in human neo- 
plastic tissues such as parathyroid adenoma [29] and ovar- 
ian cancer [30]. Moreover, there is evidence that gastric 
tumor cells show different patterns of endogenous phos- 
phorylated proteins from those in normal tissues [31]. In 
contrast, we found that myosin light chain kinase, another 
CaM kinase, was less distributed in gastric carcinoma in 
the preliminary experiments (data not shown), suggesting 
the increase in a CaM kinase I /V  level is unlikely to be 
non-specific. 
The second peak of the kinase activity separated on 
HPLC gel filtration chromatography as not been identi- 
fied in this study. Since CaM kinase II is a heterooligomer 
composed of a few subunits [15], the second peak would 
result from an oligomer of CaM kinase II subunits which 
poorly react with the antibody. Otherwise, it could be a 
degraded form of CaM kinase II, another CaM kinase 
isozyme or other protein kinases which phosphorylate 
syntide-2. It is also possible phosphorylation f syntide-2 
by either CaM kinases I /V  and/or II was enhanced in 
these fractions by (a) concomitant activator(s) of these 
kinases. Indeed, a few CaM-dependent kinases which acti- 
vate CaM kinase I have recently been identified and 
cloned [32,33]. The second peak would be a heteromer of 
these activators/kinases. 
Autophosphorylation of CaM kinases is involved in the 
control of their activities [15,27]. In the present experi- 
ment, the ce subunit of CaM kinase II, but not CaM kinase 
I /V  was found to be autophosphorylated. It is possible 
that the CaM kinase I /V  in human gastric carcinoma 
might be mutated and therefore did not retain the au- 
tophosphorylating activity. Also we cannot exclude the 
possibility that the quantity of purified CaM kinase I /V  
was not sufficient o undergo detectable autophosphoryla- 
tion. Alternatively, we may lose the co-factor of CaM 
kinase I /V,  which may potentiate autophosphorylation, 
during the purification. We have recently suggested that 
the activity of CaM kinase I /V  may be increased by 
phosphorylation of this kinase via a novel kinase in a 
calmodulin-dependent manner [32]. The activating kinase, 
called the kinase activator of CaM kinase I /V,  appears to 
be associated with the CaM kinase I /V  rather tightly, but, 
it is plausible that such activator(s) could become dissoci- 
ated during purification procedures. We could not find any 
substantial differences among other properties of these 
kinases from the native forms. The fact that expression of 
this kinase was distributed not only in the tumor cells, but 
also at the bottom of the foveoral epithelium and in the 
gastric gland in normal mucosa leads us to suggest hat 
CaM kinase I /V  may be preferentially expressed in 
rapidly-growing cells. 
It is, of course, too early for a definitive conclusion that 
protein phosphorylation by the overexpressed kinase is 
involved in cellular functions uch as cell growth. Ca 2÷- 
signalling is considered to participate in mitogenesis of 
tumor cells [34]. For example, calboxyamido triazole, 
which blocks receptor-operated Ca 2÷ channels, inhibits 
proliferation and migration of human cancer cells [35]. 
Intracellular levels of calmodulin is specifically increased 
in transformed cells [5], and growth of sarcoma cells can 
be inhibited by the calmodulin antagonist, W-7 [36]. Par- 
ticipation of CaM kinases in cell growth is also supported 
by inhibition of cell cycle by KN-62 [37]. Although this 
inhibitor was initially reported to be specific to CaM 
kinase II [24], later studies revealed its inhibitory effects 
on CaM kinases IV and V [14]. CaM kinase I /V,  there- 
fore, may function as a component of a signal network or a 
kinase cascade in the cell by interacting with other kinases, 
for example, tyrosine kinase(s). 
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